NCT04157842

Brief Summary

Explore the influence of hip replacement on lower extremity hemodynamics in Crowe Ⅳ hip dysplasia patient.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2019

Longer than P75 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 23, 2019

Completed
9 days until next milestone

Study Start

First participant enrolled

November 1, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 8, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

November 8, 2019

Status Verified

October 1, 2019

Enrollment Period

2 years

First QC Date

October 23, 2019

Last Update Submit

November 6, 2019

Conditions

Outcome Measures

Primary Outcomes (6)

  • Hip Harris Score

    change of hip harris score scale from baseline(preoperative) to 1 year after surgery.

    preoperative, 1 week, 6 weeks, 12 weeks, 24 weeks and 1 year after the surgery.

  • Leg Length Change

    change of Leg Length from baseline(preoperative) to 1 year after surgery.

    preoperative, 1 week, 6 weeks, 12 weeks, 24 weeks and 1 year after the surgery.

  • Radiographic Results

    change of Radiographic Results from 1 week after surger to 1 year after surgery

    1 week, 12 weeks, 24 weeks and 1 year after the surgery.

  • Lower Limb Arterial CT Angiography

    change of vascular diameter and vascular cross-sectional from baseline(preoperative) to 1 year after surgery baseline(preoperative) to 12 weeks after surgery.

    preoperative, 1 week, 12 weeks after the surgery.

  • Vascular Ultrasound Examination

    change of systolic peak velocity, end-diastolic velocity, pulsation index, resistance index and blood flow from baseline(preoperative) to 1 year after surgery.

    preoperative, 1 week, 6 weeks, 12 weeks, 24 weeks and 1 year after the surgery.

  • Blood Viscosity

    change of blood viscosity from baseline(preoperative) to 1 year after surgery.

    preoperative, 1 week, 6 weeks, 12 weeks, 24 weeks and 1 year after the surgery.

Study Arms (2)

total hip replacement with subtrochanteral osteotomy

EXPERIMENTAL

subtrochanteral osteotomy is applied during total hip replacement

Procedure: total hip replacement with subtrochanteral osteotomy

total hip replacement with no osteotomy

SHAM COMPARATOR

no osteotomy is applied during total hip replacement.

Procedure: total hip replacement with no osteotomy

Interventions

applying subtrochanteral osteotomy during the operation to release the tension of vessels and nerve

total hip replacement with subtrochanteral osteotomy

just total hip replacement

total hip replacement with no osteotomy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Unilateral Crow IV hip dysplasia;
  • Bilateral Crow IV hip dysplasia without osteoarthritis on the other side

You may not qualify if:

  • Patients with serious medical disease;
  • Patients with lower extremity vascular disease; 3. Patients with severe mental illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hip Dislocation

Interventions

Arthroplasty, Replacement, Hip

Condition Hierarchy (Ancestors)

Joint DislocationsJoint DiseasesMusculoskeletal DiseasesWounds and InjuriesHip Injuries

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • SHIGUI YAN, MD

    2nd affiliated hospital, School of Medicine, Zhejiang University

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2019

First Posted

November 8, 2019

Study Start

November 1, 2019

Primary Completion

November 1, 2021

Study Completion

November 1, 2023

Last Updated

November 8, 2019

Record last verified: 2019-10